Treatment of Brain Metastases from Germ Cell Tumors

Hematology/Oncology Clinics of North America

Volumn 25, Issue 3, 2011, Pages 605-613

  Oechsle, Karin ^a   Bokemeyer, Carsten ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Brain metastases; Cerebral metastases; Chemotherapy; Germ cell tumor; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; PLATINUM DERIVATIVE; STEROID; VINBLASTINE; VINCRISTINE;

AREA UNDER THE CURVE; BLOOD BRAIN BARRIER; BONE METASTASIS; BRAIN METASTASIS; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG PENETRATION; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MULTIMODALITY CANCER THERAPY; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; STEROID THERAPY; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; VISCERAL METASTASIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROSURGICAL PROCEDURES; RADIOTHERAPY; TESTICULAR NEOPLASMS;

EID: 79955916623     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2011.03.012     Document Type: Review

References (35)

1. Williams S.D., Einhorn L.H. Brain metastases in disseminated germinal neoplasms: incidence and clinical course. Cancer 1979, 44:1514-1516.
2. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997, 15:594-603.
3. Spears W.T., Morphis J.G., Lester S.G., et al. Brain metastases and testicular tumors: long-term survival. Int J Radiat Oncol Biol Phys 1992, 22:17-22.
4. Logothetis C.J., Samuels M.L., Trindade A. The management of brain metastases in germ cell tumors. Cancer 1982, 49:12-18.
5. Raghavan D., Mackintosh J.F., Fox R.M., et al. Improved survival after brain metastases in non-seminomatous germ cell tumours with combined modality treatment. Br J Urol 1987, 60:364-367.
6. Rustin G.J., Newlands E.S., Bagshawe K.D., et al. Successful management of metastatic and primary germ cell tumors in the brain. Cancer 1986, 57:2108-2113.
7. Krege S., Beyer J., Souchon R., et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008, 53:497-513.
8. Bokemeyer C., Nowak P., Haupt A., et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997, 15:1449-1454.
9. Fossa S.D., Bokemeyer C., Gerl A., et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 1999, 85:988-997.
10. Kollmannsberger C., Nichols C., Bamberg M., et al. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol 2000, 11:553-559.
11. Oechsle K., Kollmannsberger C., Honecker F., et al. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy. Eur J Cancer 2008, 44:1663-1669.
12. Boyle H.J., Droz J., Jouanneau E., et al. Management of brain metastases from germ cell tumors. J Clin Oncol 2008, 26(15s):16076.
13. Salvati M., Piccirilli M., Raco A., et al. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment. Neurosurg Rev 2006, 29:130-137.
14. Gerl A., Clemm C., Kohl P., et al. Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metastasis 1994, 12:226-230.
15. Raina V., Singh S.P., Kamble N., et al. Brain metastasis as the site of relapse in germ cell tumor of testis. Cancer 1993, 72:2182-2185.
16. Cohn D.A., Stuart-Harris R. Isolated central nervous system relapse of non-seminomatous germ cell tumour of the testis. A case report and review of the literature. Oncology 2001, 61:184-188.
17. Crabb S.J., McKendrick J.J., Mead G.M. Brain as sanctuary site of relapse in germ cell cancer patients previously treated with chemotherapy. Clin Oncol (R Coll Radiol) 2002, 14:287-293.
18. Azar J.M., Einhorn L.H., Schneider B.P. Is the blood-brain barrier relevant in metastatic germ cell tumors?. Int J Radiat Oncol Biol Phys 2007, 69:163-166.
19. Oechsle K., Lorch A., Honecker F., et al. Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor. Oncology 2010, 78:47-53.
20. Ginsberg S., Kirshner J., Reich S., et al. Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study. Cancer Treat Rep 1981, 65:477-483.
21. Balmaceda C., Heller G., Rosenblum, et al. Chemotherapy without irradiation - a novel approach for newly diagnosed CNS germ-cell tumors: results of an international cooperative trial. J Clin Oncol 1996, 14:2908-2915.
22. Kollmannsberger C., Nichols C., Meisner C., et al. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling. Ann Oncol 2000, 11:1115-1120.
23. Hartmann J.T., Nichols C.R., Droz J.P., et al. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol 2002, 13:1017-1028.
24. Fosså S.D., Stenning S.P., Gerl A., et al. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 1999, 80:1392-1399.
25. Beyer J., Kramar A., Mandanas R., et al. High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 1996, 14:2638-2645.
26. International Prognostic Factors Study Group, Lorch A., Beyer J., et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 2010, 28:4906-4911.
27. Krege S., Beyer J., Souchon R., et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008, 53:478-496.
28. Stewart O.J., Richard M., Hugenholtz H., et al. VP-16 (VP) and VM-26 (VM) penetration into human brain tumors (BT). Proc Am Assoc Cancer Res 1983, 24:133.
29. Gremmer R., Schröder M.L., Bokkel ten Huinink W.W., et al. Successful management of brain metastases from malignant germ cell tumors with standard induction chemotherapy. J Neurooncol 2008, 90:335-339.
30. Mahalati K., Bilen C.Y., Ozen H., et al. The management of brain metastasis in nonseminomatous germ cell tumours. BJU Int 1999, 83:457-461.
31. Nonomura N., Nagahara A., Oka D., et al. Brain metastases from testicular germ cell tumors: a retrospective analysis. Int J Urol 2009, 16:887-893.
32. Lutterbach J., Spetzger U., Bartelt S., et al. Malignant germ cell tumors metastatic to the brain: a model for a curable neoplasm? The Freiburg experience and a review of the literature. J Neurooncol 2002, 58:147-156.
33. Doyle D.M., Einhorn L.H. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases. Int J Radiat Oncol Biol Phys 2008, 70:1361-1364.
34. Hartmann J.T., Bamberg M., Albers P., et al. Multidisciplinary treatment and prognosis of patients with central nervous system metastases from testicular germ cell tumor origin [abstract]. Proc Am Soc Clin Oncol 2003, 22:400. [abstract: 1607].
35. NCCN Clinical Practice Guidelines in Oncology: Testicular Cancer. Version 1, 2011. Available at: Accessed April 9, 2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.